House immunization authorization bill
Rep. Waxman's (D-Calif.) Health Subcommittee passes legislation (HR 5230) to authorize childhood vaccination programs in fiscal 1987 and establish a spending ceiling of $78 mil. -- $13 mil. more than the current ceiling and $22 mil. more than the House-passed 1987 HHS appropriations bill would allocate. The measure also directs the department to maintain a six-month stockpile of vaccines, to avoid a shortage in the event a vaccine manufacturer experiences difficulty obtaining liability insurance and stops production.
You may also be interested in...
With list due 4 November, there may not be time for public comment. Meanwhile, where will biopharma find fill/finish capacity?
Lorbrena is approved as a second-line treatment for ALK-positive NSCLC but Pfizer believes data from the first-line Phase III CROWN study makes the drug a serious competitor to standard of care Alecensa in the first-line setting.
A new analysis of the ADAURA study shows that Tagrisso’s disease-free survival benefits in early stage EGFRm NSCLC are replicated for brain metastases, a common complication with a poor prognosis. Filings and OS data await.